Essential diagnostic imaging agents to help identify disease and improve patient care
Improved diagnostic information for better patient management
Lantheus Releases Comprehensive Strategic Plan for Progenics
Lantheus Holdings, Inc. Reports Third Quarter 2019 Financial Results
Lantheus Holdings to Present at the Credit Suisse 28th Annual Healthcare Conference
The medical art of diagnosis is greatly facilitated by providing physicians access to diagnostic images with the greatest possible degree of definition, contrast and detailed information so that diagnostic certainty is increased and the number of uninterpretable or poorly interpretable images is reduced.
Lantheus Releases Comprehensive Strategic Plan for Progenics
Lantheus Holdings, Inc. Reports Third Quarter 2019 Financial Results
Lantheus Holdings to Present at the Credit Suisse 28th Annual Healthcare Conference
At Lantheus, we develop, manufacture and commercialize essential diagnostic imaging agents and products that help healthcare professionals identify disease and improve patient treatment and care.
Setting the standard for diagnostic quality, safety and commitment with the leading echocardiography contrast agent in North America.
We are developing next generation imaging agents to enhance the accuracy, reliability and safety of diagnostic imaging.
Setting the standard for diagnostic quality, safety and commitment with the leading echocardiography contrast agent in North America.